Bulls REASONS TO BUY
Bears REASONS TO SELL
April 21, 2014
(Samurai Trader, 10/4/13)
STJ was no on my radar for any reason, and shouldn't have been, as the price relative line has been moving sideways for a few months now. However, it has turned up and is rising, which should put it on the price relative...(read more)
(Stock Blog Hub, 9/15/13)
St. Jude Medical Inc. (STJ) commenced the EnligHTNment trial study at the EuroPCR to analyze the effectiveness of its EnligHTN Multi-Electrode Renal Denervation System in reducing...(read more)
(Stock Blog Hub, 7/9/13)
Medical devices major, St. Jude Medical Inc. (STJ) has won CE Mark approval for its ILUMIEN OPTIS Percutaneous Coronary Intervention (PCI) Optimization System. This...(read more)
St. Jude Medical (STJ) Company Overview
St. Jude Medical (NYSE:STJ) makes devices for cardiovascular and neurological conditions, including mechanical heart valves, pacemakers, and catheters. The company generates the majority of its revenue from its Cardiac Rhythm Management (CRM) division, which makes implantable cardiac rhythm devices (ICDs) and pacemakers. The company earned $4.7 billion in revenue and $777 million in 2009.
St. Jude is dependent on the market for implantable cardiac defibrillators; roughly one-third of the company's revenue came from its ICD business. Sales of ICDs have have stagnated in recent years. Several studies suggest that a majority of patients eligible to receive ICDs don't actually receive referrals for the devices from their doctors, implying that the market for ICDs may be smaller than initially estimated by ICD manufacturers.(Read more at Wikinvest )
What's in this STJ analysis on Wikinvest...